James Noble - 01 Jul 2022 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ James Julian Noble
Issuer symbol
ADAP
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
01 Jul 2022, 17:02:06 UTC
Previous filing
02 Jul 2021
Next filing
02 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +710,711 $0.000000 710,711 01 Jul 2022 Ordinary Shares 710,711 $0.2800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount.